Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

In patients with gastrointestinal cancers treated with fluoropyrimidine-based chemotherapy agents, better overall survival at ...

Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating statins.

The lack of effect on QoL and oxygen consumption help cement the idea that the disease isn’t the same as obstructive HCM.

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Clinicians need to address maternal health at all stages, with some seeing a possible new role for GLP-1 drugs.